Roivant Sciences Ltd., 10% Owner at Urovant Sciences Ltd. (UROV), bought 27,662 shares at $8.02 ($218K) on 2019-06-05, disclosed to the SEC on 2019-06-06.
Scheduled purchase ($218k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.59 | 7,500 | $57K | 26.1% |
| 2 | $8.02 | 6,540 | $52K | 24.0% |
| 3 | $8.02 | 6,540 | $52K | 24.0% |
| 4 | $8.00 | 7,082 | $57K | 25.9% |
| Total | $7.90 avg | 27,662 | $218K | 100% |
| Filing → |
| IMVT | BUY | 2023-10-04 | $58.0M | — | Filing → |
| IMVT | BUY | 2022-10-07 | $2.5M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |